Ocular microemulsion of brinzolamide: Formulation, physicochemical characterization, and in vitro irritation studies based on EpiOcular™ eye irritation assay

References

• Abdelbary G. 2011. Ocular ciprofloxacin hydrochloride mucoadhesive chitosan-coated liposomes. Pharm Dev Technol. 16(1):44–56.
   PubMed Web of Science ®Google Scholar
• Abelson MB, Udell IJ, Weston JH. 1981. Normal human tear pH by direct measurement. Arch Ophthalmol. 99(2):301–301.
   PubMedGoogle Scholar
• Akhter S, Anwar M, Siddiqui MA, Ahmad I, Ahmad J, Ahmad MZ, Bhatnagar A, Ahmad FJ. 2016. Improving the topical ocular pharmacokinetics of an immunosuppressant agent with mucoadhesive nanoemulsions: formulation development, in-vitro and in-vivo studies. Colloids Surf B Biointerfaces. 148:19–29.
   PubMed Web of Science ®Google Scholar
• Amarji B, Garg NK, Singh B, Katare OP. 2016. Microemulsions mediated effective delivery of methotrexate hydrogel: more than a tour de force in psoriasis therapeutics. J Drug Target. 24(2):147–160.
   PubMed Web of Science ®Google Scholar
• Arthur S, Cantor LB. 2011. Update on the role of alpha-agonists in glaucoma management. Exp Eye Res. 93(3):271–283.
   PubMed Web of Science ®Google Scholar
• Bachu RD, Stepanski M, Alzhrani RM, Jung R, Boddu SHS. 2018. Development and evaluation of a novel microemulsion of dexamethasone and tobramycin for topical ocular administration. J Ocul Pharmacol Ther. 34(4):312–324.
   PubMed Web of Science ®Google Scholar
• Baranowski P, Karolewicz B, Gajda M, Pluta J. 2014. Ophthalmic drug dosage forms: characterisation and research methods. Sci World J. 2014:1–14.
   Web of Science ®Google Scholar
• Bharti SK, Kesavan K. 2017. Phase-transition W/O microemulsions for ocular delivery: evaluation of antibacterial activity in the treatment of bacterial keratitis. Ocul Immunol Inflamm. 25(4):463–474.
   PubMed Web of Science ®Google Scholar
• Bin-Jumah M, Gilani SJ, Jahangir MA, Zafar A, Alshehri S, Yasir M, Kala C, Taleuzzaman M, Imam SS. 2020. Clarithromycin-loaded ocular chitosan nanoparticle: formulation, optimization, characterization, ocular irritation, and antimicrobial activity. IJN. 15:7861–7875.
   Web of Science ®Google Scholar
• Bruschi ML, editor. 2015. Mathematical models of drug release. In: Strategies to modify the drug release from pharmaceutical systems. San Diego (CA): Elsevier; p. 63–86.
   Google Scholar
• Chhibber T, Wadhwa S, Chadha P, Sharma G, Katare OP. 2015. Phospholipid structured microemulsion as effective carrier system with potential in methicillin sensitive Staphylococcus aureus (MSSA) involved burn wound infection. J Drug Target. 23(10):943–952.
   PubMed Web of Science ®Google Scholar
• Corporation Mattek. 2015. EpiOcular TM Eye Irritation Test (OCL-200-EIT) for the prediction of acute ocular irritation of chemicals This protocol was submitted to the OECD in 2014 and approved as the new. Ashland (MA): Corporation Mattek; p. 1–47.
   Google Scholar
• Dash S, Murthy PN, Nath L, Chowdhury P. 2010. Kinetic modeling on drug release from controlled drug delivery systems. Acta Pol Pharm. 67(3):217–223.
   PubMed Web of Science ®Google Scholar
• Destruel PL, Zeng N, Brignole-Baudouin F, Douat S, Seguin J, Olivier E, Dutot M, Rat P, Dufaÿ S, Dufaÿ-Wojcicki A, et al. 2020. In situ gelling ophthalmic drug delivery system for the optimization of diagnostic and preoperative mydriasis: in vitro drug release, cytotoxicity and mydriasis pharmacodynamics. Pharmaceutics. 12(4):360–319.
   Web of Science ®Google Scholar
• Ege MA, Karasulu Y, Güneri T. 2004. Triangle phase diagram analysis software. 4th Int Postgrad Res Symp Pharm, İstanbul.
   Google Scholar
• Ei Hlaing NH, Pakpayat N, Boonme P. 2020. Stability and release kinetics of natural oil microemulsions containing nicotinamide. J Cosmet Sci. 71(1):23–36.
   PubMed Web of Science ®Google Scholar
• El Agamy HI, El Maghraby GM. 2015. Natural and synthetic oil phase transition microemulsions for ocular delivery of tropicamide: efficacy and safety. J Appl Pharm Sci. 5(Suppl 2):67–75.
   Google Scholar
• Eskandar M, Anayatollah Salimi ASR. 2013. A microemulsion system for controlled corneal delivery of timolol. IRJPAS.3(4):32–39.
   Google Scholar
• Figueiredo KA, Neves JKO, da Silva JA, de Freitas RM, Carvalho ALM. 2016. Phenobarbital loaded microemulsion: development, kinetic release and quality control. Braz J Pharm Sci. 52(2):251–264.
   Web of Science ®Google Scholar
• Garg T, Malik B, Rath G, Goyal AK. 2014. Development and characterization of nano-fiber patch for the treatment of glaucoma. Eur J Pharm Sci. 53:10–16.
   PubMed Web of Science ®Google Scholar
• Garti N, Avrahami M, Aserin A. 2006. Improved solubilization of Celecoxib in U-type nonionic microemulsions and their structural transitions with progressive aqueous dilution. J Colloid Interface Sci. 299(1):352–365.
   PubMed Web of Science ®Google Scholar
• Gaudana R, Ananthula HK, Parenky A, Mitra AK. 2010. Ocular drug delivery. Aaps J. 12(3):348–360.
   PubMed Web of Science ®Google Scholar
• Gautam N, Kesavan K. 2017. Development of microemulsions for ocular delivery. Ther Deliv. 8(5):313–330.
   PubMed Web of Science ®Google Scholar
• Geyer O, Levo Y. 2020. Glaucoma is an autoimmune disease. Autoimmun Rev. 19(6):102535.
   PubMed Web of Science ®Google Scholar
• Ghate D, Edelhauser HF. 2006. Ocular drug delivery. Expert Opin Drug Deliv. 3(2):275–287.
   PubMedGoogle Scholar
• Gohil R, Patel A, Pandya T, Dharamsi A. 2019. Optimization of brinzolamide loaded microemulsion using formulation by design approach: characterization and in-vitro evaluation. Curr Drug Ther. 15(1):37–52.
   Web of Science ®Google Scholar
• Gorantla S, Rapalli VK, Waghule T, Singh PP, Dubey SK, Saha RN, Singhvi G. 2020. Nanocarriers for ocular drug delivery: current status and translational opportunity. RSC Adv. 10(46):27835–27855.
   Web of Science ®Google Scholar
• Gote V, Sikder S, Sicotte J, Pal D. 2019. Ocular drug delivery: present innovations and future challenges. J Pharmacol Exp Ther. 370(3):602–624.
   PubMed Web of Science ®Google Scholar
• Gupta A, Nayak K, Misra M. 2019. Cow ghee fortified ocular topical microemulsion; in vitro, ex vivo, and in vivo evaluation. J Microencapsul. 36(7):603–621.
   PubMed Web of Science ®Google Scholar
• Habib F, El-Mahdy M, Abdel-Hafez A, Maher S. 2012. Microemulsion for ocular delivery: ocular irritancy test and in vivo studies of anti-inflammatory action. J Drug Deliv Sci Technol. 22(6):541–544.
   Web of Science ®Google Scholar
• Habib F, El-Mahdy M, Maher S. 2011. Microemulsions for ocular delivery: evaluation and characterization. J Drug Deliv Sci Technol. 21(6):485–489.
   Web of Science ®Google Scholar
• Hegde RR, Bhattacharya SS, Verma A, Ghosh A. 2014. Physicochemical and pharmacological investigation of water/oil microemulsion of non-selective beta blocker for treatment of glaucoma. Curr Eye Res. 39(2):155–163.
   PubMed Web of Science ®Google Scholar
• Hegde RR, Verma A, Ghosh A. 2013. Microemulsion: new insights into the ocular drug delivery. ISRN Pharm. 2013:826798–826711.
   PubMedGoogle Scholar
• Higginbotham EJ. 2010. Considerations in glaucoma therapy: fixed combinations versus their component medications. Clin Ophthalmol. 4:1–9.
   PubMedGoogle Scholar
• Hwang S-J, Kang H, Cha K-H, Cho W, Park J, Park HJ, Sun BK, Hyun S-M. 2016. Cyclosporine A micellar delivery system for dry eyes. Int J Nanomedicine. 11:2921–2933.
   PubMed Web of Science ®Google Scholar
• Ibrahim MM, Maria DN, Wang X, Simpson RN, Hollingsworth TJ, Jablonski MM. 2020. Enhanced corneal penetration of a poorly permeable drug using bioadhesive multiple microemulsion technology. Pharmaceutics. 12(8):704.
   Web of Science ®Google Scholar
• ICH. 2008. ICH official web site. ICH.IchOrg.
   Google Scholar
• Iester M. 2008. Brinzolamide ophthalmic suspension: a review of its pharmacology and use in the treatment of open angle glaucoma and ocular hypertension. Clin Ophthalmol. 2(3):517–523.
   PubMedGoogle Scholar
• Ja’Afar SM, Khalid RM, Othaman R, Mokhtar WNAW, Ramli S. 2019. Coconut oil based microemulsion formulations for hair care product application. JSM. 48(3):599–605.
   Google Scholar
• Jain N, Verma A, Jain N. 2020. Formulation and investigation of pilocarpine hydrochloride niosomal gels for the treatment of glaucoma: intraocular pressure measurement in white albino rabbits. Drug Deliv. 27(1):888–899.
   PubMed Web of Science ®Google Scholar
• Jumelle C, Gholizadeh S, Annabi N, Dana R. 2020. Advances and limitations of drug delivery systems formulated as eye drops. J Control Release. 321:1–22.
   PubMed Web of Science ®Google Scholar
• Kalam MA, Alshamsan A, Aljuffali IA, Mishra AK, Sultana Y. 2016. Drug delivery of gatifloxacin using microemulsion as vehicle: formulation, evaluation, transcorneal permeation and aqueous humor drug determination. Drug Deliv. 23(3):886–7544.
   Web of Science ®Google Scholar
• Kesarla R, Tank T, Vora PA, Shah T, Parmar S, Omri A. 2016. Preparation and evaluation of nanoparticles loaded ophthalmic in situ gel. Drug Deliv. 23(7):2363–2370.
   PubMed Web of Science ®Google Scholar
• Khatun R, Ashraful Islam SM. 2014. Development and validation of analytical method for simultaneous estimation of brinzolamide and timolol by HPLC from opthalmic preparation. Int J Pharm Sci Res. 43:1001–1007.
   Google Scholar
• Kumar R, Sinha VR. 2014. Preparation and optimization of voriconazole microemulsion for ocular delivery. Colloids Surf B Biointerfaces. 117:82–88.
   PubMed Web of Science ®Google Scholar
• Kumar R, Sinha VR. 2017. Evaluation of ocular irritation and bioavailability of voriconazole loaded microemulsion. Curr Drug Deliv. 14(5):718–724.
   PubMed Web of Science ®Google Scholar
• Lazcano-Gomez G, Ramos-Cadena M de los A, Torres-Tamayo M, Hernandez de Oteyza A, Turati-Acosta M, Jimenez-Román J. 2016. Cost of glaucoma treatment in a developing country over a 5-year period. Medicine. 95(47):e5341.
   PubMed Web of Science ®Google Scholar
• Li H, Liu Y, Zhang Y, Fang D, Xu B, Zhang L, Chen T, Ren K, Nie Y, Yao S, et al. 2016. Liposomes as a novel ocular delivery system for brinzolamide: in vitro and in vivo studies. AAPS PharmSciTech. 17(3):710–717.
   PubMed Web of Science ®Google Scholar
• Li J, Liu H, Liu LL, Cai CN, Xin HX, Liu W. 2014. Design and evaluation of a brinzolamide drug-Resin in situ thermosensitive gelling system for sustained ophthalmic drug delivery. Chem Pharm Bull. 62(10):1000–1008.
   PubMed Web of Science ®Google Scholar
• Li J, Wang X, Xu G, Deng R, Wu L, Zhang L, Chen Z. 2020. Comparison of the effectiveness and safety of travoprost and latanoprost for the management of open-angle glaucoma given as an evening dose. Exp Ther Med. 20(5):1–1.
   PubMed Web of Science ®Google Scholar
• Lidich N, Garti-Levy S, Aserin A, Garti N. 2019. Potentiality of microemulsion systems in treatment of ophthalmic disorders: keratoconus and dry eye syndrome – in vivo study. Colloids Surf B Biointerfaces. 173:226–232. (September 2018):
   PubMed Web of Science ®Google Scholar
• Lim LT, Ah-Kee EY, Collins CE. 2014. Common eye drops and their implications for pH measurements in the management of chemical eye injuries. Int J Ophthalmol. 7(6):1067–1068.
   PubMed Web of Science ®Google Scholar
• Liu B, Gordon WP, Richmond W, Groessl T, Tuntland T. 2016. Use of solubilizers in preclinical formulations: effect of Cremophor EL on the pharmacokinetic properties on early discovery compounds. Eur J Pharm Sci. 87:52–57.
   PubMed Web of Science ®Google Scholar
• Liu Y, Zhao J, Zhong X, Wei Q, Huang Y. 2019. Efficacy and safety of brinzolamide as add-on to prostaglandin analogues or β-blocker for glaucoma and ocular hypertension: a systematic review and meta-analysis. Front Pharmacol. 10:679.
   PubMed Web of Science ®Google Scholar
• Lorenzo-Veiga B, Diaz-Rodriguez P, Alvarez-Lorenzo C, Loftsson T, Sigurdsson HH. 2020. In vitro and ex vivo evaluation of nepafenac-based cyclodextrin microparticles for treatment of eye inflammation. Nanomaterials. 10(4):709.
   Web of Science ®Google Scholar
• Lotz C, Schmid FF, Rossi A, Kurdyn S, Kampik D, De Wever B, Walles H, Groeber FK. 2016. Alternative methods for the replacement of eye irritation testing. ALTEX. 33(1):55–67.
   PubMedGoogle Scholar
• Lusthaus JA, Goldberg I. 2017. Brimonidine and brinzolamide for treating glaucoma and ocular hypertension; a safety evaluation. Expert Opin Drug Saf. 16(9):1071–1078.
   PubMed Web of Science ®Google Scholar
• Mahboobian MM, Foroutan SM, Aboofazeli R. 2016. Brinzolamide-loaded nanoemulsions: in vitro release evaluation. Iran J Pharm Sci. 12(3):75–93.
   Google Scholar
• Mahboobian MM, Mohammadi M, Mansouri Z. 2020. Development of thermosensitive in situ gel nanoemulsions for ocular delivery of acyclovir. J Drug Deliv Sci Technol. 55:101400.
   Web of Science ®Google Scholar
• Mahboobian MM, Seyfoddin A, Rupenthal ID, Aboofazeli R, Foroutan SM. 2017. Formulation development and evaluation of the therapeutic efficacy of brinzolamide containing nanoemulsions. Iran J Pharm Res. 16(3):847–857.
   PubMed Web of Science ®Google Scholar
• Mirani A, Kundaikar H, Velhal S, Patel V, Bandivdekar A, Degani M, Patravale V. 2019. Tetrahydrocurcumin-loaded vaginal nanomicrobicide for prophylaxis of HIV/AIDS: in silico study, formulation development, and in vitro evaluation. Drug Deliv Transl Res. 9(4):828–847.
   PubMed Web of Science ®Google Scholar
• Moghimipour E, Salimi A, Changizi S. 2017. Preparation and microstructural characterization of griseofulvin microemulsions using different experimental methods: SAXS and DSC. Adv Pharm Bull. 7(2):281–289.
   PubMed Web of Science ®Google Scholar
• Negri L, Ferreras A, Iester M. 2019. Timolol 0.1% in glaucomatous patients: efficacy, tolerance, and quality of life. J Ophthalmol. 2019:1–12.
   Web of Science ®Google Scholar
• Ochiuz L, Hortolomei M. 2017. Development of microemulsion dermal products based on avocado oil for topical administration. In: Karunaratne N, Pamunuwa G, Ranatunga JKU, editors. Properties and uses of microemulsions. London: InTech.
   Google Scholar
• OECD. 2013. OECD 438 – isolated chicken eye method for identifying i) chemicals inducing serious eye damage and ii) chemicals not requiring classification for eye irritation or serious eye damage. Paris (France): OECD.
   Google Scholar
• OECD. 2015. OECD Guideline for testing of chemicals No. 492. Reconstructed human cornea-like epithelium (RhCE) test method for identifying chemicals not requiring classification and labelling for eye irritation or serious eye damage. Paris (France): OECD.
   Google Scholar
• Olejnik A, Kapuscinska A, Schroeder G, Nowak I. 2017. Physico-chemical characterization of formulations containing endomorphin-2 derivatives. Amino Acids. 49(10):1719–1731.
   PubMed Web of Science ®Google Scholar
• Paolino D, Tudose A, Celia C, Di Marzio L, Cilurzo F, Mircioiu C. 2019. Mathematical models as tools to predict the release kinetic of fluorescein from lyotropic colloidal liquid crystals. Materials. 12(5):693.
   PubMed Web of Science ®Google Scholar
• Patel RB, Patel MR, Bhatt KK, Patel BG. 2013. Formulation consideration and characterization of microemulsion drug delivery system for transnasal administration of carbamazepine. Bull Fac Pharm Cairo Univ. 51(2):243–253.
   Google Scholar
• Patil A, Lakhani P, Taskar P, Avula B, Majumdar S. 2020. Carboxyvinyl polymer and guar-borate gelling system containing natamycin loaded PEGylated nanolipid carriers exhibit improved ocular pharmacokinetic parameters. J Ocul Pharmacol Ther. 36(6):410–420.
   PubMed Web of Science ®Google Scholar
• Patil A, Singh S, Opere C, Dash A. 2017. Sustained-release delivery system of a slow hydrogen sulfide donor, GYY 4137, for potential application in glaucoma. AAPS PharmSciTech. 18(6):2291–2302.
   PubMed Web of Science ®Google Scholar
• Peppas NA, Narasimhan B. 2014. Mathematical models in drug delivery: how modeling has shaped the way we design new drug delivery systems. J Control Release. 190:75–81.
   PubMed Web of Science ®Google Scholar
• Pfannenbecker U, Bessou-Touya S, Faller C, Harbell J, Jacob T, Raabe H, Tailhardat M, Alépée N, De Smedt A, De Wever B, et al. 2013. Cosmetics Europe multi-laboratory pre-validation of the EpiOcular™ reconstituted human tissue test method for the prediction of eye irritation. Toxicol in Vitro. 27(2):619–626.
   PubMed Web of Science ®Google Scholar
• Pozarowska D. 2010. Safety and tolerability of tafluprost in treatment of elevated intraocular pressure in open-angle glaucoma and ocular hypertension. Clin Ophthalmol. 4:1229–1236.
   PubMedGoogle Scholar
• Quigley HA, Broman A. 2006. The number of people with glaucoma worldwide in 2010 and 2020. Br J Ophthalmol. 90(3):262–267.
   PubMed Web of Science ®Google Scholar
• Radomska-Soukharev A, Wojciechowska J. 2005. Microemulsions as potential ocular drug delivery systems: phase diagrams and physical properties depending on ingredients. Acta Pol Pharm. 62(6):465–471.
   PubMedGoogle Scholar
• Rajasekaran A, Arul Kumaran KSG, Preetha JP, Karthika AK. 2010. A comparative revıew on conventıonal and advanced ocular drug delıvery formulatıons. Int J PharmTech Res. 2(1):668–674.
   Google Scholar
• Salimi A, Panahi-Bazaz M-R, Panahi-Bazaz E. 2017. A novel microemulsion system for ocular delivery of azithromycin: design, characterization and ex-vivo rabbit corneal permeability. Jundishapur J Nat Pharm Prod. 12(2):1–11.
   Web of Science ®Google Scholar
• Seok SH, Lee S-A, Park E-S. 2018. Formulation of a microemulsion-based hydrogel containing celecoxib. J Drug Deliv Sci Technol. 43:409–414.
   Web of Science ®Google Scholar
• Sheybani A, Scott R, Samuelson TW, Kahook MY, Bettis DI, Ahmed IIK, Stephens JD, Kent D, Ferguson TJ, Herndon LW. 2020. Open-angle glaucoma: burden of illness, current therapies, and the management of nocturnal IOP variation. Ophthalmol Ther. 9(1):1–14.
   PubMed Web of Science ®Google Scholar
• Siafaka PI, Titopoulou A, Koukaras EN, Kostoglou M, Koutris E, Karavas E, Bikiaris DN. 2015. Chitosan derivatives as effective nanocarriers for ocular release of timolol drug. Int J Pharm. 495(1):249–264.
   PubMed Web of Science ®Google Scholar
• Sipahi H, Reis R, Dinc O, Kavaz T, Dimoglo A, Aydın A. 2019. In vitro biocompatibility study approaches to evaluate the safety profile of electrolyzed water for skin and eye. Hum Exp Toxicol. 38(11):1314–1326.
   PubMed Web of Science ®Google Scholar
• Sun J, Zhou Z. 2018. A novel ocular delivery of brinzolamide based on gellan gum: in vitro and in vivo evaluation. Drug Des Devel Ther. 12:383–389. Volume
   PubMed Web of Science ®Google Scholar
• Tighsazzadeh M, Mitchell JC, Boateng JS. 2019. Development and evaluation of performance characteristics of timolol-loaded composite ocular films as potential delivery platforms for treatment of glaucoma. Int J Pharm. 566:111–125.
   PubMed Web of Science ®Google Scholar
• Torres-Luna C, Hu N, Koolivand A, Fan X, Zhu Y, Domszy R, Yang J, Yang A, Wang NS. 2019. Effect of a cationic surfactant on microemulsion globules and drug release from hydrogel contact lenses. Pharmaceutics. 11(6):262.
   Web of Science ®Google Scholar
• Ustündağ Okur N, Apaydın S, Karabay Yavaşoğlu NÜ, Yavaşoğlu A, Karasulu HY. 2011. Evaluation of skin permeation and anti-inflammatory and analgesic effects of new naproxen microemulsion formulations. Int J Pharm. 416(1):136–144.
   PubMed Web of Science ®Google Scholar
• Üstündağ Okur N, Çağlar EŞ, Pekcan AN, Okur ME, Ayla Ş. 2019. Preparation, optimization and in vivo anti-inflammatory evaluation of hydroquinone loaded microemulsion formulations for melasma treatment. JRP. 23(4):662–670.
   Google Scholar
• Üstündağ Okur N, Çağlar EŞ, Siafaka PI. 2020. Novel ocular drug delivery systems: an update on microemulsions. J Ocul Pharmacol Ther. 36(6):342–354.
   PubMed Web of Science ®Google Scholar
• Üstündağ Okur N, Gökçe EH, Eğrilmez S, Özer Ö, Ertan G. 2014. Novel ofloxacin-loaded microemulsion formulations for ocular delivery. J Ocul Pharmacol Ther. 30(4):319–332.
   PubMed Web of Science ®Google Scholar
• Üstündağ Okur N, Yozgatli V, Okur ME. 2020. In vitro-in vivo evaluation of tetrahydrozoline-loaded ocular in situ gels on rabbits for allergic conjunctivitis management . Drug Dev Res. 81(6):716–727.
   PubMed Web of Science ®Google Scholar
• Üstündağ Okur N, Yozgatlı V, Okur ME, Yoltaş A, Siafaka PI. 2019. Improving therapeutic efficacy of voriconazole against fungal keratitis: thermo-sensitive in situ gels as ophthalmic drug carriers. J Drug Deliv Sci Technol. 49:323–333.
   Web of Science ®Google Scholar
• Weerapol Y, Limmatvapirat S, Nunthanid J, Sriamornsak P. 2014. Self-nanoemulsifying drug delivery system of nifedipine: impact of hydrophilic-lipophilic balance and molecular structure of mixed surfactants. AAPS PharmSciTech. 15(2):456–464.
   PubMed Web of Science ®Google Scholar
• Wu W, Li J, Wu L, Wang B, Wang Z, Xu Q, Xin H. 2013. Ophthalmic delivery of brinzolamide by liquid crystalline nanoparticles: in vitro and in vivo evaluation. AAPS PharmSciTech. 14(3):1063–1071.
   PubMed Web of Science ®Google Scholar
• Yotsawimonwat S, Okonoki S, Krauel K, Sirithunyalug J, Sirithunyalug B, Rades T. 2006. Characterisation of microemulsions containing orange oil with water and propylene glycol as hydrophilic components. Pharmazie. 61(11):920–926.
   PubMed Web of Science ®Google Scholar
• Zeng L, Xin X, Zhang Y. 2017. Development and characterization of promising Cremophor EL-stabilized o/w nanoemulsions containing short-chain alcohols as a cosurfactant. RSC Adv. 7(32):19815–19827.
   Web of Science ®Google Scholar